KRAS and neoplasm: In mouse models, KRAS-mutant PanIN lesions show inflammation, COX2 overexpression, and early infiltration of immunosuppressive cells like T regulatory cells (Tregs), tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs) [57].